The Duke Cancer Institute (DCI) wants to assure our patients that the safety of our patients, their loved ones, our team members and the community at large remains our highest priority. We are closely monitoring this rapidly evolving situation and are implementing all necessary precautions to prevent the spread of infection.

For the latest information about how we are keeping our community safe, please visit

Angels Among Us


all news

Poliovirus therapy for recurrent glioblastoma has three-year survival rate of 21 percent.

Read More

Feature Story

all stories

Poliovirus Treatment Now Available to Pediatric Patients

Duke's Preston Robert Tisch Brain Tumor Center is now enrolling qualified pediatric patients in our new PVSRIPO clinical trial for children. This exciting trial is designed for pediatric patients with recurring brain tumors. A similar trial has shown promising results for our adult patients. Eric Thompson, MD, will serve as principal investigator. Visit to learn more.

Angels Among Us is the largest and most successful fundraising effort of its kind in all of North Carolina. Funds raised support brain cancer research at The Preston Robert Tisch Brain Tumor Center. Help make a difference. The below buttons help you connect with Angels Among Us and the many ways to get involved.